Aeglea BioTherapeutics

Aeglea BioTherapeutics

Drugs for the treatment of tumors the company was incorporated in 2013 and is based in texas.

Launch date
Employees
Market cap
€1.4b
Enterprise valuation
€1.0b (Public information from Sep 2024)
Austin Texas (HQ)
Authorizing premium user...